New Jersey A 3049: Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.

Status: Introduced in the Assembly, Referred to Assembly Health Committee (as of 2020-02-20)

State: New Jersey · Session: 219 · Bill: A 3049

Subjects: PHARMACEUTIC

Sponsors: Lampitt, Pamela R., Caputo, Ralph R.

View New Jersey A 3049 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.